These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21747684)

  • 1. Study on the expression and clinical significances of lewis y antigen and integrin αv, β3 in epithelial ovarian tumors.
    Wang Y; Liu J; Lin B; Wang C; Li Q; Liu S; Yan L; Zhang S; Iwamori M
    Int J Mol Sci; 2011; 12(6):3409-21. PubMed ID: 21747684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Lewis y antigen and integrin αv, β3 in ovarian cancer and their relationship with chemotherapeutic drug resistance.
    Gao J; Hu Z; Liu D; Liu J; Liu C; Hou R; Gao S; Zhang D; Zhang S; Lin B
    J Exp Clin Cancer Res; 2013 Jun; 32(1):36. PubMed ID: 23725446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and correlation of Lewis y antigen and TGF-β1 in ovarian epithelial carcinoma.
    Wang ST; Liu JJ; Wang CZ; Lin B; Hao YY; Wang YF; Gao S; Qi Y; Zhang SL; Iwamori M
    Oncol Rep; 2012 Apr; 27(4):1065-71. PubMed ID: 22138668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-expression of Lewis y antigen with human epididymis protein 4 in ovarian epithelial carcinoma.
    Zhuang H; Gao J; Hu Z; Liu J; Liu D; Lin B
    PLoS One; 2013; 8(7):e68994. PubMed ID: 23894390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stimulation of IGF-1R expression by Lewis(y) antigen provides a powerful development mechanism of epithelial ovarian carcinoma.
    Liu D; Liu J; Wang C; Lin B; Liu Q; Hao Y; Zhang S; Iwamori M
    Int J Mol Sci; 2011; 12(10):6781-95. PubMed ID: 22072919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression.
    Hou R; Jiang L; Liu D; Lin B; Hu Z; Gao J; Zhang D; Zhang S; Iwamori M
    Int J Mol Med; 2017 Aug; 40(2):293-302. PubMed ID: 28586014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoresistance is associated with MUC1 and Lewis y antigen expression in ovarian epithelial cancers.
    Zhang D; Gao J; Zhu L; Hu Z; Hou R; Liu S; Tan M; Liu J; Lin B
    Int J Mol Sci; 2013 May; 14(6):11024-33. PubMed ID: 23708102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemical expression of integrin alphav, beta5 and beta3 in ovarian epithelial carcinoma: correlation with drug resistance of chemotherapy].
    Guo HY; Han JS; Zhang LF; Wang LN; Geng L; Chen GA
    Zhonghua Fu Chan Ke Za Zhi; 2004 Nov; 39(11):750-3. PubMed ID: 15634501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of annexin II and Lewis y antigen in ovarian epithelial tumors and the correlation between them.
    Zhuang H; Tan M; Liu J; Li X; Gao J; Hu Z; Deng L; Zhu L; Lin B
    Tumour Biol; 2015 Apr; 36(4):2343-9. PubMed ID: 25416440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and correlation of Lewis y antigen and integrins α5 and β1 in ovarian serous and mucinous carcinoma.
    Li Q; Liu S; Lin B; Yan L; Wang Y; Wang C; Zhang S
    Int J Gynecol Cancer; 2010 Dec; 20(9):1482-9. PubMed ID: 21119363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrins and haptoglobin: Molecules overexpressed in ovarian cancer.
    Villegas-Pineda JC; Garibay-Cerdenares OL; Hernández-Ramírez VI; Gallardo-Rincón D; Cantú de León D; Pérez-Montiel-Gómez MD; Talamás-Rohana P
    Pathol Res Pract; 2015 Dec; 211(12):973-81. PubMed ID: 26549463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expressions of BCL6 and Lewis y antigen are correlated with high tumor burden and poor prognosis in epithelial ovarian cancer.
    Zhu L; Feng H; Jin S; Tan M; Gao S; Zhuang H; Hu Z; Wang H; Song Z; Lin B
    Tumour Biol; 2017 Jul; 39(7):1010428317711655. PubMed ID: 28671040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CD147 and Lewis y antigen in ovarian cancer and their relationship to drug resistance.
    Gao J; Hu Z; Liu J; Liu D; Wang Y; Cai M; Zhang D; Tan M; Lin B
    Med Oncol; 2014 May; 31(5):920. PubMed ID: 24692145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and promotor methylation of p73 gene in ovarian epithelial tumors].
    Zhang YL; Guo XR; Shen DH; Cheng YX; Liang XD; Chen YX; Wang Y
    Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):33-8. PubMed ID: 22455848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collagen triple helix repeat containing 1 (CTHRC1) activates Integrin β3/FAK signaling and promotes metastasis in ovarian cancer.
    Guo B; Yan H; Li L; Yin K; Ji F; Zhang S
    J Ovarian Res; 2017 Oct; 10(1):69. PubMed ID: 29021002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of Lewis y and integrin α5β1 correlate with chemotherapeutic drug resistance in epithelial ovarian carcinoma.
    Hu Z; Gao S; Gao J; Hou R; Liu C; Liu J; Li B; Liu D; Zhang S; Lin B
    Int J Mol Sci; 2012 Nov; 13(12):15588-600. PubMed ID: 23443083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AlphaV- and beta1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients.
    Davidson B; Goldberg I; Reich R; Tell L; Dong HP; Trope' CG; Risberg B; Kopolovic J
    Gynecol Oncol; 2003 Aug; 90(2):248-57. PubMed ID: 12893184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunohistochemical expression of p53 and Ki67 in ovarian epithelial borderline tumors. Correlation with clinicopathological factors.
    Giurgea LN; Ungureanu C; Mihailovici MS
    Rom J Morphol Embryol; 2012; 53(4):967-73. PubMed ID: 23303020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of Lewis y antigen and CD44 is correlated with resistance to chemotherapy in epithelial ovarian cancers.
    Hu Z; Gao J; Zhang D; Liu Q; Yan L; Gao L; Liu J; Liu D; Zhang S; Lin B
    PLoS One; 2013; 8(2):e57250. PubMed ID: 23468946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co‑expression of Lewis y antigen and CD147 in epithelial ovarian cancer is correlated with malignant progression and poor prognosis.
    Liu J; Liu Q; Wang Y; Liu M; Qi Y; Gao J; Lin B
    Int J Mol Med; 2019 Apr; 43(4):1687-1698. PubMed ID: 30816446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.